07.20.22 -- Meeting The Biopharma Market's Diverse Manufacturing Needs

Late-phase development requires a holistic development strategy driven by a well-defined target product profile. This webinar aims to provide you with an overview of the complex path to a successful product launch.

In today’s crowded market, drug manufacturers must understand the challenges associated with creating a chemistry, manufacturing, and controls (CMC) strategy and the expertise and resources you need to successfully execute it.

This webinar focuses on the critical CMC elements of a product’s life cycle and how Lonza applies its knowledge and experience to provide the regulatory submissions support and strategy necessary for a successful biologic drug application (BLA) application.

A new business and operating model may address the build or buy dilemma, offering an innovative and agile way to manage demand uncertainty and reduce the risks associated with early investment decisions.

Meeting the needs of the modern biomanufacturing landscape requires a combination of technology and digital solutions working together to effectively and efficiently meet your goals.

As the field of biologics increases its focus on identifying new diseases to target and novel constructs to treat them, innovative administration devices are once again in the spotlight.